Kidney Transplant Market Ready to Achieve Revenue Growth of US$ 106,179 Mn by 2028
Kidney Transplant Market |
Kidney transplant is a medical procedure that involves the replacement of a diseased or damaged kidney with a healthy one from a donor. The market for kidney transplant has been expanding rapidly in recent years due to several factors, including an increasing prevalence of chronic kidney disease (CKD), advancements in transplantation techniques, and a rising demand for organ transplantation.
Chronic kidney disease
is a major contributor to the expansion of the Kidney
Transplant Market. According to the Centers for Disease Control
and Prevention (CDC), approximately 37 million people in the United States have
CKD. CKD can progress to end-stage renal disease (ESRD), a condition where the
kidneys fail to function adequately, and dialysis or kidney transplant becomes
necessary for survival. Kidney transplant is often considered the preferred
treatment option for ESRD, as it offers a better quality of life and survival
rates compared to dialysis.
The global Kidney Transplant Market is estimated to be valued at US$ 81,037 Mn in 2021 and is expected to register a CAGR of 3.1% and reach US$ 1,06,179 Mn by 2028.
Advancements in transplantation techniques have also played a significant role in the expansion of the Kidney Transplant Market. In recent years, there have been several improvements in surgical techniques, immunosuppressive medications, and donor selection criteria that have resulted in higher success rates and reduced complications for kidney transplant recipients. For example, the use of minimally invasive laparoscopic techniques for donor nephrectomy has reduced post-operative pain, shortened hospital stays, and improved recovery time for donors. Furthermore, the development of new immunosuppressive medications with fewer side effects has improved patient outcomes and reduced the risk of organ rejection.
Another factor driving the expansion of the Kidney Transplant Market is the rising demand for organ transplantation. As the population ages and the prevalence of chronic diseases such as diabetes and hypertension increases, the number of patients requiring kidney transplant is expected to grow. However, the supply of donor organs has not kept pace with the demand. According to the United Network for Organ Sharing (UNOS), there are currently over 100,000 people in the United States waiting for a kidney transplant. To address this shortage, several initiatives have been launched to increase organ donation rates, such as public awareness campaigns, improvements in donor identification and referral, and the use of living donor transplantation.
Major Vendors are Organ recovery systems, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics Inc., Novartis AG, Pfizer Inc., Novartis Inc., B. Braun Melsungen AG, Transonic Systems Inc., and Transonic Systems Inc.
Comments
Post a Comment